For example, in Burkitt’s lymphoma, the use of doxorubicin treatment can cause the thymus to release IL-6 and tissue inhibitor of metalloproteinase 1 (TIMP1), causing the remaining lymphoma tissue to resist the drug, which leads to the recurrence of lymphoma (Gilbert and Hemann, 2010). Here, IL6 is linked to lymphoma.